Adenosine and pain: Recent findings with directly and indirectly acting agents

Drug Development Research

Volumn 45, Issue 3-4, 1998, Pages 304-311

  Sawynok, Jana ^a   Doak, Greg ^a   Poon, Anthony ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Adenosine deaminase; Adenosine kinase; Nociception

Indexed keywords

ADENOSINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A1 RECEPTOR; ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE A2 RECEPTOR; ADENOSINE A3 RECEPTOR; ADENOSINE DEAMINASE; ADENOSINE DEAMINASE INHIBITOR; ADENOSINE KINASE; ADENOSINE KINASE INHIBITOR; ANALGESIC AGENT; CAFFEINE; EXCITATORY AMINO ACID; KETANSERIN; MEPYRAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PENTOSTATIN; PROSTAGLANDIN E2; SEROTONIN; SEROTONIN RECEPTOR; SUBSTANCE P;

ANALGESIA; ANALGESIC ACTIVITY; ANTINOCICEPTION; CONFERENCE PAPER; DOSE RESPONSE; DRUG MECHANISM; DRUG RECEPTOR BINDING; HISTAMINE RELEASE; HUMAN; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MAST CELL DEGRANULATION; NEUROTRANSMITTER RELEASE; NOCICEPTION; PAIN; PATHOPHYSIOLOGY; REGULATORY MECHANISM; SPINAL CORD;

EID: 0032452749     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2299(199811/12)45:3/4<304::AID-DDR29>3.0.CO;2-L     Document Type: Conference Paper

References (62)

1. 2A receptors potentiates pain produced by inflammatory mediators. Neuropharmacology 35:99-110.
2. 1 antinociception, tolerance and withdrawal. J Neurosci 17:735-744.
3. Amér S, Meyerson BA. 19SS. Lack of analgesic effect of opioids on neuropathic and idiopatliic forms of pain. Pain 33:11-23.
4. Blechen T, Keele CA. 1977. Observations on the algogenic actions of adenosine compounds on the human blister base preparation. Pain 3:367-377.
5. Caliill CM, White TD, Sawynok J. 1997. Substance P releases and augments the morphine-evoked release of adenosine from spinal cord. Brain Res 760:294-297.
6. Cao YQ, Mantyh PW, Carlson EJ, Gillespe AM, Epstein CJ, Basbaum AI. 1998. Primar)1 afferent tachykinins are required to experience moderate to intense pain. Nature 392:390-393.
7. Conway CM, Marsala M, Somogyi GT, Yaksh TL. 1997. Intrathecal NMDA-induced release of spinal adenosine and amino acids. Soc Neurosci Abstr 23:1013.
8. Corradetti R, Lo Conte G, Moroni F, Passini MB, Pepeu G. 1984. Adenosine decreases aspartate and glutamate release from rat hippocampus slices. Eur J Pharmacol 104:19-26.
9. Craig CG, White TD. 1992. Low-level iY-methyl-D-aspartate receptor activation provides a purinergic inhibitory threshold against further N-metliyl-D-aspartate-mediated neurotransmission in the cortex. J Pharmacol Exp Ther 260:1278-1284.
10. Crea F, Gaspardone A. 1997. New look at an old symptom: angina pectoris. Circulation 96:3766-3773.
11. Crea F, Pupita G, Galassi AR, El-Tamimi H, Kaski JC, Davies G, Maseri A. 1990. Role of adenosine in pathogenesis of anginal pain. Circulation 81:164-172.
12. Cronstein BN. 1994. Adenosine, an endogenous anti-inflammatory agent. J Appl Physiol 76:5-13.
13. Cronstein BN. 1995. A novel approach to the development of antiinflammatory agents: adenosine release at inflamed sites. J Invest Med 43:50-57.
14. Cronstein BN, Naime D, Firestein G. 1995. The antiinflammatory effects of an adenosine kinase inhibitor are mediated by adenosine. Arthritis Rheum 38:1040-1045.
15. De Felipe C, Herrero JE O'Brien JA, Palmer JA, Doyle CA, Smith AJH, Laird JMA, Celmonte C, Cervero F, Hunt SE 199S. Altered antinociception, analgesia and aggression in mice lacking the receptor for substance E Nature 392:394-397.
16. DeLander GE, Hopkins CJ. 1987. Involvement of A? adenosine receptors in spinal mechanisms of antinociception. Eur J Pharmacol 139:215-223.
17. DeLander GE, Wahl JJ. 19S8. BAavior induced by putative nociceptive neurotransmitters is inhibited by adenosine or adenosine analogs coadministered intrathecally. J Pharmacol Exp Ther 246: 565-570.
18. Dickenson AH. 1995. Central acute pain mechanisms. Ann Med 27:223-227.
19. Doak GJ, Sawynok J. 1995. Complex role of peripheral adenosine in the genesis of the response to subcutaneous formalin in the rat. Eur J Phannacol 281:311-318.
20. Doak GJ, Sawynok J. 1997. Formalin-induced nociceptive behavior and edema: involvement of multiple peripheral 5-hydroxytryp famine receptor subtypes. Neuroscience 80:939-949.
21. Dray A. 1995. Inflammatory mediators of pain. Br J Anaesthesia 75:125-131.
22. Euchner-Wamser I, Melier ST, Gebhart GE 1994. A model of cardiac nociception in chronically instrumented rats: behavioral and electrophysiological effects of pericardial administration of algogenic substances. Pain 58:117-128.
23. Gaspardone A, Crea E Tomai E lamele M, Crossman DC, Pappagallo M, Versaci E Chiariello L, Giolfre PA. 1994. Substance P potentiates the algogenic effects of intraarterial infusion of adenosine. J Am Coll Cardiol 24:477-482.
24. Geiger JD, Parkinson FE, Kowaluk EA. 1997. Regulators of endogenous adenosine levels as therapeutic agents. In: Jacobson KA, Jarvis ME editors. Purinergic approaches in experimental therapeutics. New York: Wiley-Liss. p 55-84.
25. Golembiowska K, While TD, Sawynok J. 1995. Modulation of adenosine release from rat spinal cord by adenosine deaminase and adenosine kinase inhibitors. Brain Res 699:315-320.
26. Golembiowska K, White TD, Sawynok J. 1996. Adenosine kinase inhibitors augment release of adenosine from spinal cord slices. Eur J Pharmacol 307:157-162.
27. Guieu R, Peragnt JC, Roussel P, Hassani H, Sampieri E Bechis G, Gola R, Rochat H. 1996. Adenosine and neuropathic pain. Pain 68:271-274.
28. Handwerker HO, Reeh PW. 1991. Pain and inflammation. In: Bond MR, Charlton JE, Woold CJ, editors. Proceedings of the VI th World Congress on Pain. Amsterdam: Eisevier, p 59-70.
29. Hong Y, Abbott FV. 1994. Behavioural effects of intraplantar injection of inflammatory mediators in the rat. Neuroscience 63:827-836.
30. Karlsten R, Gordh T, Hartvig P Post C. 1990. Effects of intrathecal injection of the adenosine receptor agonists R-phenylisopropyl-adenosine and N-ethylcarboxamide-adenosine on nociception and motor function in the rat. Anesth Analg 71:60-64.
31. Karlsten R, Post C, Hide I, Daly JW. 1991. The antinociceptive effect of intrathecally administered adenosine analogs in mice correlates with the affinity for the Aj-adenosine receptor. Neurosci Lett 121:267-270.
32. Karlsten R, Gordh T, Post C. 1992. Local antinociceptive and hyperalgesic effects in the formalin test after peripheral administration of adenosine analogues in mice. Phannacol Toxicol 70:434-438.
33. Keil GJ II, DeLander GE. 1992. Spinally-mediated antinociception is induced in mice by an adenosine kinase-, but not by an adenosine deaminase-, inhibitor. Life Sei 51:171-176.
34. Khasar SG, Wang J-E Taiwo YO, Heller PH, Green PG, Levine JD. 1995. Mu-opioid agonist enhancement of prostaglandin-induced hyperalgesia in the rat: a G-protein βγ subunit-mediated effect? Neuroscience 67:189-195.
35. Lee Y-W, Yaksh TL. 1996. Pharmacology of the spinal adenosine receptor which mediates the antiallodynic action of intrathecal adenosine agonists. J Pharmacol Exp Ther 277:1642-1648.
36. 3 receptors: pharmacological properties, species differences and receptor functions. Trends Phannacol Sei 15:298-306.
37. Lloycl HGE, Fredliolm BB. 1995. Involvement of aclenosine cleaminase and aclenosine kinase in regulating extracellular aclenosine concentration in rat hippocampal slices. Neurochem Int 26:387-395.
38. Mao J, Price DD, Mayer DJ. 1995. Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions. Pain 62:259-274.
39. Murray TE Zhang G, Franklin PH. 1993. Manipulation of endogenous adenosine affects seizure susceptibility. Dnig Dev Res 28:410-415.
40. Nakamura I, Ohta Y, Kemmotsu O. 1997. Characterization of adenosine receptors mediating spinal sensory transmission related to nociceptive information in the rat. Anesthesiology 87:577-584.
41. + channels in antinociception induced by R-PIA, an adenosine AI receptor agonist. Naunyn Schmiedebergs Arch Pharmacol 350:57-62.
42. Pierce PA, Xie GX, Levine JD, Peroutka SJ. 1996.5-Hydroxytryptamine receptor subtype messenger RNAs in rat peripheral sensory and sympathetic ganglia: a polymerase chain reaction study. Neuroscience 70:553-559.
43. Poon A, Sawynok J. 1995. Autinociception by adenosine analogs and an adenosine kinase inhibitor: dependence on formalin concentration. Eur J Pharmacol 286:177-184.
44. Poon A, Sawynok J. 1998. Antinociception by adenosine analogs and inhibitors of adenosine metabolism in an inflammatory thermal hyperalgesia model in the rat. Pain 74:235-245.
45. Poon A, Sawynok J, Alien GV, Esser MJ. 1997. Local antiinflammatory and systemic antinociceplive effects produced by a combination of adenosine kinase and adenosine deaminase inhibitors. Soc Neurosci Abstr 23:1814.
46. Portenoy RK, Foley KM, Inturrisi CE. 1990. The nature of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from studies of opioid infusions. Pain 43:273-286.
47. Reeve AJ, Dickenson AH. 1995. The roles of spinal adenosine receptors in the control of acute and more persistent nociceptive responses of dorsal horn neurones in the anaesthetized rat. Br J Pharmacol 116:2221-2228.
48. Salter MW, De Konick Y, Henry JL. 1992. ATP-sensitive K+-channels mediate an IPSP in dorsal horn neurons elicited by sensory stimulation. Synapse 11:214-220.
49. Santicioli P, Del Bianco E, Maggi CA. 1993. Adenosine AI receptors mediate the presynaptic inhibition of calcitonin gene-related peptide release by adenosine in the rat spinal cord. Eur J Pharmacol 231:139-142.
50. Sawynok J. 1998. Adenosine receptor activation and nociception. Eur J Pharmacol 317:1-11.
51. Sanynok J, Zarrindast M-R, Reid AR, Doak GJ. 1997. Adenosine As receptor activation produces nociceptive behaviour and edema by release of histamine and 5-hydroxytryptamine. ÉEur J Pharmacol 333:1-7.
52. Sawynok J, Reid A, Poon A. 1998. Peripheral antinociceptive effect of an adenosine kinase inhibitor, with augmentation by an adenosine deaminase inhibitor, in the rat formalin test. Pain 74:75-81.
53. Segherdahl and Sollevi. 199S. This issue DDR 9S-067.
54. Sjölund KE Sollevi A, Segerdahl M, Lundeberg T. 1997. Intrathecal adenosine analog administration reduces substance P in cercbrospinal fluid along with behavioral effects that suggest antinociception in rats. Aneslh Analg 85:627-632.
55. Sosnowski M, Yaksh TL. 19S9. Role of spinal adenosine receptors in modulating the hyperesthesia produced by spinal glycine receptor antagonism. Anesth Analg 69:587-592.
56. Stein C. 1995. The control of pain in peripheral tissue by opioids. N Engl J Med 332:1685-1690.
57. Sylvén C, Beennann B, Jonzon B, Brandt R. 19S6. Angina pectorislike pain provoked by intravenous adenosine in healthy volunteers. Br Med J 293:227-230.
58. Taiwo YO, Levine JD. 1990. Direct cutaneous hyperalgesia induced by adenosine. Neuroscience 38:757-762.
59. Taiwo YO, Bjerknes LK, Coetzl EJ, Levine JD. 1989. Mediation of primary afferent peripheral hyperalgesia by the cAMP second messenger. Neuroscience 32:577-580.
60. Woolf CJ, Doubell TR 1994. The pathophysiology of chronic pain: increased sensitivity to low threshold Aß-fibre inputs. Curr Opin Neurobiol 4:525-534.
61. Yaksh TL. 19S9. Behavioural and autonomie correlates of the tactile evoked allodynia produced by spinal glycine inhibition: effects of modulatory receptor systems and excitatory amino acid antagonists. Pain 37:111-123.
62. Yaksh TL. 1993. The spinal actions of opioids. In: Herz A, editor. Handbook of experimental pharmacology. Berlin: Springer-Verlag, p 53-90.